BIOV:CA BioVaxys Technology Corp

CAD 0.08 0.00 0
Icon

BioVaxys Technology Corp (BIOV:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | CNSX
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.08

0.00 (0.00)%

CAD 0.01B

0.03M

N/A

N/A

Icon

BIOV:CA

BioVaxys Technology Corp (CAD)
COMMON STOCK | CNSX
CAD 0.08
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.01B

N/A

CAD 0.08

BioVaxys Technology Corp (BIOV:CA) Stock Forecast

N/A

Based on the BioVaxys Technology Corp stock forecast from 0 analysts, the average analyst target price for BioVaxys Technology Corp is not available over the next 12 months. BioVaxys Technology Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioVaxys Technology Corp is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, BioVaxys Technology Corp’s stock price was CAD 0.08. BioVaxys Technology Corp’s stock price has changed by +0.00% over the past week, -5.88% over the past month and +77.78% over the last year.

No recent analyst target price found for BioVaxys Technology Corp
No recent average analyst rating found for BioVaxys Technology Corp

Company Overview BioVaxys Technology Corp

BioVaxys Technology Corp., a clinical-stage immunotherapeutic company, engages in developing antiviral and anticancer vaccine platforms. It develops BVX-0320, a SARS-CoV-2 vaccine; BVX-1021, a vaccine for the strain of coronavirus that causes SARS1; and BVX-0918, a haptenized tum...Read More

N/A

N/A

0

N/A

CAD

Canada

Adjusted Closing Price for BioVaxys Technology Corp (BIOV:CA)

Loading...

Unadjusted Closing Price for BioVaxys Technology Corp (BIOV:CA)

Loading...

Share Trading Volume for BioVaxys Technology Corp Shares

Loading...

Compare Performance of BioVaxys Technology Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOV:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BioVaxys Technology Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACOG:CA
Alpha Cognition Inc. +0.06 (+9.09%) CAD0.10B N/A -8.05

ETFs Containing BIOV:CA

Symbol Name BIOV:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BioVaxys Technology Corp (BIOV:CA) Stock

Stock Target Advisor's fundamental analysis for BioVaxys Technology Corp's stock is Very Bearish.

Unfortunately we do not have enough data on BIOV:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOV:CA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIOV:CA's stock to indicate if its overvalued.

The last closing price of BIOV:CA's stock was CAD 0.08.

The most recent market capitalization for BIOV:CA is CAD 0.01B.

Unfortunately we do not have enough analyst data on BIOV:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BioVaxys Technology Corp's stock.

As per our most recent records BioVaxys Technology Corp has 0 Employees.

Sorry we do not have any infomation available on BioVaxys Technology Corp's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...